Dov Bergwerk - 04 Nov 2026 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Nov 2026, 16:01:54 UTC
Prior SEC filing
08 Oct 2026
Next SEC filing
12 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dov Bergwerk
Filing notes and source

Key filing fact

Dov Bergwerk filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 06 Nov 2026.

Key facts

  • This page summarizes Dov Bergwerk's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2026, 16:01.

Change

  • Previous filing in this sequence was filed on 08 Oct 2026.
  • Current net transaction value: -$1,095,567.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001997381 Primary reporting owner

Bergwerk Dov

Relationship
Interim Cheif Legal Officer
Address
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HA'NEVIA STREET, TEL AVIV, ISRAEL
Signature
/s/ Dov Bergwerk
Signature date
06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+17,505
Change %
+147%
Price
$34.70*
Shares after
29,448
Date
04 Nov 2026
Ownership
Direct
TEVA transaction

Ordinary Shares

Sale

Transaction value
-$730,309
Shares
-17,505
Change %
-59%
Price
$41.72
Shares after
11,943
Date
04 Nov 2026
Ownership
Direct
TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+8,755
Change %
+73%
Price
$28.98*
Shares after
20,698
Date
04 Nov 2026
Ownership
Direct
TEVA transaction

Ordinary Shares

Sale

Transaction value
-$365,259
Shares
-8,755
Change %
-42%
Price
$41.72
Shares after
11,943
Date
04 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares
-17,505
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
17,505
Exercise price
$34.70
Footnotes
F1
TEVA transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares
-8,755
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Nov 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
8,755
Exercise price
$28.98
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 4,377 having vested on March 3, 2021.

Footnote F2

Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020, and 2,191 having vested on May 24, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .